🕒 Last update: loading…16/11/2026

Stock Doximity, Inc. DOCS

Doximity, Inc. — Investlytic score 3/5 on the five criteria.

-
-
60/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 3/5 criteria met. Data as of 01/11/2026.

  • ❌ Price trend failed
  • ✅ Growth passed
  • ✅ Debt passed
  • ✅ P/E passed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2021 → 2022: -33.05%

Price change 2022 → 2023: -16.45%

Price change 2023 → 2024: 90.41%

Price change 2024 → 2025: -17.06%

Price change 2025 → 2026: -24.15%

Price change 2026 (year to date): -22.42%

Financial growth

Revenue CAGR (8 years): 33.42%

Earnings CAGR (8 years): 58.41%

Growth status: positive trend (>1%/yr) in revenue and earnings.

Debt

Debt-to-equity ratio: 0.01

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 21.96

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 1.94% from the high over 6 months.

Insufficient correction (< 10.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Doximity, Inc.21.20.01+33.4 %🔒
Hims & Hers Health, Inc.–2.07+74.7 %–
Merit Medical Systems, Inc.22.30.57+11.5 %–
Ionis Pharmaceuticals, Inc.–5.34+15.5 %–
Option Care Health, Inc.18.40.96+18.7 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Doximity, Inc. over the latest fiscal years.

Revenue
645 m USD
fiscal year 2026
Net income
196 m USD
fiscal year 2026
Net margin
30.4 %
fiscal year 2026
Average annual growth
+25.5 %
Revenue growth over 5 years
Market cap
5.9 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
2021207 m50.2 m24.3 %n/a
2022344 m155 m45.0 %+66.0 %
2023419 m113 m26.9 %+22.0 %
2024475 m148 m31.0 %+13.5 %
2025570 m223 m39.1 %+20.0 %
2026645 m196 m30.4 %+13.1 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Doximity, Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
solid accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
23.65
safe zone (above 2.99)
Piotroski Score
6 / 9
4 to 6: average accounts
DCF Value
25.32 USD
DCF below share price · share price 33.76 USD, gap -25.0 %
Net Debt / EBITDA
-0.95 x
net cash
Fiscal year20222023202420252026
Cash and investments798 m841 m763 m916 m749 m
Total Debt1.1 m15.6 m14.5 m12.4 m10.2 m
Net Debt-112 m-142 m-82.2 m-197 m-209 m
Equity879 m966 m901 m1.1 bn951 m
Total assets991 m1.1 bn1.1 bn1.3 bn1.1 bn
Operating cash flow127 m180 m184 m273 m326 m
Investments (capex)5.7 m6.2 m147,0006.5 m9.0 m
Free cash-flow121 m173 m178 m267 m317 m
Share buybacks2.7 m85.3 m281 m120 m432 m
Dividends paid00000

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)44.27 x
Price / book value6.39 x
Return on Equity (ROE)14.8 %
Return on Invested Capital (ROIC)12.6 %
Net margin21.1 %
Debt / equity0.01 x
Current ratio6.37 x
Free cash-flow yield5.0 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.

+

Valuation and competitors

Doximity, Inc. compared with its sector on the same exchange and with its main competitors.

Company P/E
21.8
21.4 % below the sector
Sector median P/E
27.7
healthcare, NYSE
Sector over 10 years
22.3
10-year median, range 18.4 to 44.9

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Doximity, Inc. publish: ratings, price targets and earnings forecasts.

Majority rating
hold
24 analysts
Average price target
30.75 USD
from n/a to n/a, 45 targets over 12 months
Gap with the share price
-5.4 %
price 32.51 USD on 06/11/2026

Breakdown of ratings

strong buy 1buy 8hold 13sell 2strong sell 0

Analysts' average target 30.75 USD, DCF value 25.32 USD, share price 32.51 USD.

Average target over the last 3 months: 30.75 USD (4 targets).

Track record against expectations: reported EPS above consensus 10 times over the last 12 releases.

Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.

+

Dividends and earnings

Doximity, Inc.: dividend history, last distributions, stock splits and earnings releases.

No known dividend for this company.

Earnings releases

DatePublished EPSExpected EPSSurprise
05/11/20260.360.35+3.4 %
06/08/20260.290.30-4.3 %
13/05/20260.260.28-7.1 %
05/02/20260.460.44+4.5 %
06/11/20250.450.38+18.8 %
07/08/20250.360.30+19.4 %

Factual data: ex-dividend history and earnings calendar, as of 15/11/2026. A past dividend does not guarantee the next one.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Doximity, Inc.

Large funds tracked
24
hold the stock as of 2026Q2
Executives (insiders)
0 / 11
0 purchases, 11 sales in 130 days
US elected officials
1
0 purchases, 1 sales in 12 months

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
Vanguard Group13.3 m588 m0.0 %+4.1 %2025Q4
BlackRock14.3 m297 m0.0 %+0.4 %2026Q2
State Street8.4 m175 m0.0 %+108.5 %2026Q2
D. E. Shaw & Co5.9 m123 m0.1 %+104.1 %2026Q2
Two Sigma Investments4.6 m96.4 m0.1 %+239.2 %2026Q2
Goldman Sachs4.1 m84.8 m0.0 %+131.8 %2026Q2
Geode Capital Management3.8 m79.8 m0.0 %-2.4 %2026Q2
Wellington Management3.1 m65.0 m0.0 %+24.7 %2026Q2

Latest insider transactions

DatePersonSideAmount
05/11/2026Cabral Timothy Ssale375,235 USD
02/11/2026Wampler Kira Scherersale65,780 USD
14/10/2026Sitaram Siddharthsale80,167 USD
01/10/2026Wampler Kira Scherersale57,820 USD
30/09/2026Yang Watkin Phoebe L.sale34,456 USD
15/09/2026Sitaram Siddharthsale54,044 USD

Elected officials' disclosures

DateOfficialSideAmount
06/11/2025Jonathan Jacksonsale$15,001 - $50,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 24/06/2021
ISIN code
US26622P1075
Workforce
827
full-time employees
Chief executive
Jeffrey A. Tangney

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Doximity, Inc.

What is the Doximity, Inc. share price?

Latest recorded price: 33.34 USD on 13/11/2026, for a market cap of 5.9 bn USD.

What is the revenue of Doximity, Inc.?

645 m USD for fiscal year 2026, with net income of 196 m USD (net margin 30.4 %).

What do analysts say about Doximity, Inc.?

Out of 24 analysts: 9 buy or strong buy, 13 hold, 2 sell or strong sell. Average price target: 30.75 USD, i.e. -5.4 % from the share price.

What is the P/E ratio of Doximity, Inc.?

Trailing 12-month P/E of 21.8, against 27.7 for the sector median on the same exchange (10-year median: 22.3).

Is Doximity, Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US26622P1075).

How many employees does Doximity, Inc. have?

827 full-time employees according to the latest published profile.

Who runs Doximity, Inc.?

Jeffrey A. Tangney is the company's chief executive.

Which large funds own Doximity, Inc.?

As of 2026Q2, among the large funds tracked: Vanguard Group, BlackRock, State Street, D. E. Shaw & Co, Two Sigma Investments.

07

Similar stocks